Wuhan General Group (China), Inc. Stock Other OTC
Equities
WUHN
US9825691051
Biotechnology & Medical Research
Financials (USD)
Sales 2011 | 128M | Sales 2012 | 80.38M | Capitalization | 1.33M |
---|---|---|---|---|---|
Net income 2011 | -3M | Net income 2012 | -10M | EV / Sales 2011 | 0.55 x |
Net Debt 2011 | 62.49M | Net Debt 2012 | 100M | EV / Sales 2012 | 1.26 x |
P/E ratio 2011 |
-1.56
x | P/E ratio 2012 |
-0.12
x | Employees | - |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 76.65% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Robinson
FOU | Founder | - | 88-07-18 |
Willem Jonker
DFI | Director of Finance/CFO | - | 20-10-04 |
Riyad Domingo
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 19-01-21 | |
Jeff Robinson
FOU | Founder | - | 88-07-18 |
1st Jan change | Capi. | |
---|---|---|
+3.13% | 43.43B | |
+48.83% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |